Kenya vs Suriname: Cause of death, by non-communicable diseases, ages 60+, female
Kenya
63.7%
in 2021
Suriname
63.9%
in 2021
Kenya rank
156th
Suriname rank
154th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Kenya
- Suriname
How they compare
Suriname currently reports 63.9% against 63.7% in Kenya, a difference of 0.2%.
Across all 6 years both countries report, Suriname has been ahead every year.
Kenya ranks 156th and Suriname ranks 154th of 185 countries.
Suriname has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kenya | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.4% | 89.9% | 38.5% | Suriname |
| 2010s | 66.2% | 90.7% | 24.5% | Suriname |
| 2020s | 65.9% | 76.4% | 10.5% | Suriname |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Kenya or Suriname?
- Suriname, at 63.9% against 63.7% in Kenya as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Kenya and Suriname?
- 0.2%, with Suriname ahead.
- How many years of comparable data are there for Kenya and Suriname?
- 6 years are reported by both, from 2000 to 2021.
- How do Kenya and Suriname rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Kenya ranks 156th and Suriname ranks 154th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.